The most instructive thing about this week’s perovskite announcement is not a device. It is a legal instrument — and what its existence says about where the field now stands. When the largest solar manufacturer in the Western Hemisphere pays for permission to develop a technology it is already developing, the bottleneck has moved. It is no longer only about making a better film. It is about who owns the right to make it at all.
On October 29, First Solar, Inc. (Nasdaq: FSLR) announced a non-exclusive patent licensing agreement with CubicPV Inc., granting First Solar access to CubicPV’s issued and pending US patents covering perovskite solar technology. The Business Wire announcement, issued from Phoenix, says the license “further clears the path” for First Solar to continue developing photovoltaic devices built with a perovskite semiconductor for the US utility-scale, commercial and industrial, and residential markets, and applies to sales and distribution of those products domestically. Other terms were not disclosed.
What the license actually buys
Freedom to operate is a term of art, and it is worth defining plainly because the press release uses it as its central claim. It does not mean owning a technology. It means being able to make, use, and sell a product without infringing someone else’s patent rights — or, more precisely, without facing a credible litigation threat from a particular patent holder. A license from CubicPV removes CubicPV from the list of potential plaintiffs for the covered US activity. It does nothing about any other patent holder.
That distinction matters more in perovskites than in most solar technologies, because the field’s patent landscape is genuinely crowded: foundational work on compositions, device architectures, deposition processes, and encapsulation spread across hundreds of assignees over fifteen years. No single portfolio covers the whole field. First Solar chief executive Mark Widmar said it plainly: “Commercializing the next generation of PV takes two things. It takes the technology development and manufacturing scaling work our R&D teams are focused on, and it takes freedom to operate, which is what this agreement helps secure.” Note the verb: helps. Not completes.
The scope is broad in one dimension and narrow in another. Broad, because it covers perovskite devices across all three US market segments rather than a single product line. Narrow, because it is confined to the United States, and because the announcement says nothing about royalties, duration, or whether the license covers manufacturing processes, device structures, materials, or all three. Those are the terms that would determine what the deal costs and how much protection it confers, and they are undisclosed. Any analysis that prices this deal would be inventing the missing half of it. This article will not.
One further limit deserves emphasis. A license is not a product launch, and nothing in the announcement should be read as one. No perovskite module efficiency is disclosed, no commercial production date is given, no capacity figure is attached to the perovskite program, and no customer or order is named. The program’s next disclosed milestone is a pilot line reaching operational readiness — a manufacturing term that means the line is ready to run, not that it is shipping product.
The second license in eight months
The CubicPV deal is not First Solar’s first perovskite license this year. It is the second, and the pairing is the story.
On February 24, 2026, First Solar announced a non-exclusive patent licensing agreement with Oxford PV, the UK perovskite-silicon tandem company, giving it access to Oxford PV’s issued patents and pending applications for continued perovskite device development in the US. That license covered the potential manufacturing and distribution of perovskite-semiconductor products in the same three US market segments, and explicitly excluded crystalline silicon semiconductors. Its other terms were likewise undisclosed.
Two non-exclusive US licenses, eight months apart, from two of the field’s most prominent patent holders, describe a deliberate strategy rather than a one-off settlement. First Solar is assembling freedom to operate portfolio by portfolio, in public, before it has a commercial perovskite product to defend. Licensing early, twice, and openly signals that its lawyers and its R&D teams are working the same roadmap: clear the legal ground while the pilot line is still being built, so the legal question does not become the gating item when the manufacturing question is answered.
It also signals something about the licensors. Oxford PV, which manufactures perovskite-on-silicon tandems in Brandenburg, Germany, and CubicPV, built around printed perovskites and tandem development, are not surrendering to First Solar. Non-exclusive licenses let them monetize foundational portfolios without giving up their own product ambitions or their ability to license the same rights to First Solar’s rivals. CubicPV chief executive Tim McCaffery framed it exactly that way: “Access to intellectual property is vital as the industry begins commercializing perovskite and tandem technologies. First Solar’s decision to license our IP is evidence of that shift and shows the relevance of our IP portfolio to the perovskite ecosystem.” The subtext is legible: the perovskite business model is shifting toward an IP licensing layer sitting on top of product competition, and CubicPV intends to be a tollkeeper in that layer.
Whether that layer becomes a thicket or a marketplace is an open debate. One view holds that broad, early, non-exclusive licensing is how a crowded field avoids the patent wars that slowed other technologies. The other holds that stacking licenses, each with undisclosed royalties, can quietly tax a future product until its cost advantage disappears. Both views fit the facts announced so far, and the royalty stack, if one is accumulating, is invisible from outside.
CubicPV, from wafer plant to patent portfolio
CubicPV’s own history explains why its portfolio is worth licensing — and why its business model now leans on licensing at all.
The company was formed in 2021 from the merger of Hunt Perovskite Technologies, a Dallas-based developer of printed metal-halide perovskite photovoltaics founded in 2013, and 1366 Technologies, a Bedford, Massachusetts company founded in 2008 around a Direct Wafer process that forms silicon wafers directly from molten silicon instead of sawing them from ingots. The name reflects the cubic crystal structure shared by silicon and perovskite, and the original pitch was a tandem module: a low-cost Direct Wafer silicon bottom cell with a printed perovskite top cell, claimed to boost panel power output by roughly 30% over single-junction modules. The merger round brought in $25 million from Hunt Energy Enterprises, Breakthrough Energy Ventures, and others — including First Solar itself.
What followed is a case study in how quickly solar manufacturing plans can be rewritten by commodity prices. CubicPV announced plans for a 10 GW conventional silicon wafer plant in the United States, backed by more than $100 million in equity commitments led by SCG Cleanergy. In February 2024, it cancelled that plant, citing a collapse in wafer prices and rising construction costs, and restructured around perovskite-silicon tandem development. The Business Wire release describes what survived that restructuring: “over a decade developing, testing and fielding perovskite technology to build a substantial body of foundational patents and intellectual property,” pursued under what the company calls a durability-first philosophy.
That phrase points at the field’s central technical problem: perovskites degrade under moisture, heat, and light, and the gap between a laboratory cell’s efficiency and a warranted module’s twenty-five-year outdoor life is where most perovskite companies fail. Whether CubicPV’s patents cover durability solutions, deposition processes, device architectures, or some combination is not disclosed. The prudent reading is that First Solar found something in the portfolio worth paying for — enough to sign a second license in a year.
The Ohio lines: what exists and what is promised
The license announcement doubles as a progress report on First Solar’s perovskite program, and the manufacturing details in it are more concrete than the legal ones.
First Solar says it has invested over $2 billion in thin-film research and development, including its perovskite program. Its investments include a new perovskite development line at its Perrysburg, Ohio campus that produces small form-factor modules featuring a perovskite semiconductor, which the company says has allowed it to meet key internal milestones covering initial-stage efficiency, stability, and manufacturability objectives. Small form-factor matters: it is the scale at which a process can be proven without betting a full-size line, and the fact that First Solar describes its milestones as “initial-stage” is a candid admission of where the program sits. These are first-gate results — the film works, it survives early stability testing, it can be made — not the results that justify a factory.
The second line is the one to watch. First Solar is investing in a larger pilot line in Ohio capable of producing modules equivalent in dimensions to its Series 6 module — the company’s large-area, glass-on-glass thin-film format, roughly two meters by 1.2 meters in its cadmium telluride form — expected to reach operational readiness in the first half of 2027. On First Solar’s third-quarter 2026 earnings call on October 29, the same day as the license announcement, management added the next step: the pilot line is expected to enable field deployment of modules “to further capture learnings and validate the manufacturing, performance, and durability profile of this next-generation thin film technology before we undertake broader scaling decisions.”
That sentence contains the whole program in miniature. Operational readiness in early 2027, then field deployment, then learning, then — only then — a scaling decision. There is no commercial production date in that sequence, and none should be inferred. A pilot line at Series 6 dimensions is a scale-up experiment, not a factory: its job is to discover whether a process that works on small modules survives meter-scale coating, lamination, and outdoor exposure at acceptable yield. First Solar’s thin-film heritage is genuinely relevant — decades of coating large glass substrates uniformly — but perovskite is a different semiconductor from cadmium telluride, with different chemistry and stability failure modes. Manufacturing experience transfers in part, not in whole, and the pilot line is where the size of that part gets measured.
The earnings call also put a number on the program’s cost, and it moved: fully perovskite-related spend, originally forecast at approximately $100 million, is now expected to total approximately $120 million, with the increase falling in 2027. That is a research-and-pilot budget, not a commercialization budget — modest against approximately $1.2 billion in third-quarter net sales, and it says nothing about what a full perovskite factory, if one is ever approved, would cost.
What the license does not settle
Three gaps remain after the signatures. First, geography. The license is US-only. First Solar manufactures internationally and sells globally; a perovskite product cleared for domestic sale is not cleared for export, and the announcement says nothing about licenses covering other jurisdictions. Oxford PV’s exclusive license to Trinasolar for China, signed in April 2025, is a reminder that perovskite IP is already carved into territorial blocks, and that the map of who can sell what where is being drawn deal by deal.
Second, completeness. Two licensors do not make a clean landscape. Other holders of foundational perovskite patents — universities, national laboratories, and companies that have not licensed to First Solar — remain outside the announced coverage. First Solar’s own cautionary statement acknowledges the surrounding risks, including the validity and scope of patent claims. The thicket is thinner after this deal. It is not gone.
Third, the technology itself. Nothing in the announcement resolves perovskite’s stability question at module scale, and nothing claims to. The small-module milestones are initial-stage, the pilot line is not yet operational, and field deployment has not begun. A license removes a legal obstacle to testing a technology. It does not make the technology pass its tests. The deal also lands two weeks after China proposed adding large-area perovskite manufacturing know-how to its export-control catalogue — a proposal this desk covered in the context of Renshuo’s Series B — so the US and Chinese ecosystems are, in parallel, building domestic capacity and fencing off manufacturing knowledge.
What to watch
Pilot-line readiness: whether the Series 6-sized Ohio line reaches operational readiness in the first half of 2027, and what First Solar discloses about its first runs. Silence after a readiness date would be as informative as data.
Field deployment: the first perovskite modules deployed outdoors from the pilot line, and the first stability data from them. Accelerated laboratory testing can estimate lifetime; only outdoor exposure validates it, and it takes calendar time.
Further licenses: whether First Solar signs a third perovskite license, and from whom. Each additional deal narrows the remaining thicket.
The scaling decision: deferred until after field deployment validates manufacturing, performance, and durability. A decision to build, or to delay, will be the first real verdict on the program.
CubicPV’s own trajectory: whether it converts its portfolio into further deals with other manufacturers, confirming McCaffery’s claim that IP access is becoming the industry’s gating transaction.
The bottom line
First Solar’s license from CubicPV should be read in exactly the register the companies used: a further clearing of the path, not the end of the road. A manufacturer with over $2 billion in thin-film R&D behind it, a small-module line meeting initial milestones, and a Series 6-sized pilot line due in early 2027 has now secured US freedom to operate from two prominent patent holders, eight months apart, while disclosing the terms of neither deal.
That is how a careful incumbent enters a new semiconductor: prove the film at small scale, license the patents before the pilot line runs, deploy in the field before committing to a factory, and say so in public at each step. It is also, at this moment, entirely preparatory. No commercial perovskite module, no production date, no disclosed efficiency, and no clearance beyond CubicPV’s portfolio and US borders has been announced. The number to watch is not a royalty that was never disclosed or a patent count that was never itemized. It is the first Series 6-sized perovskite module that survives a field deployment and comes back with its performance intact.
No investment recommendation is made or implied anywhere in this article.
Sources and further reading
- Business Wire (October 29, 2026), “First Solar, CubicPV Enter into US Patent Licensing Agreement” — the primary source for the license terms, the Perrysburg development line, the Series 6-sized pilot line and its first-half-2027 operational-readiness target, the $2 billion thin-film R&D figure, and the Widmar and McCaffery quotes. Other terms undisclosed.
- Business Wire / Oxford PV (February 24, 2026), “First Solar, Oxford PV Enter into Patent Licensing Agreement for US Markets” — the prior non-exclusive US license, its exclusion of crystalline silicon semiconductors, and its undisclosed terms.
- First Solar Q3 2026 earnings call transcript (October 29, 2026) — the Ohio pilot line’s field-deployment purpose and the perovskite spend revision from approximately $100 million to approximately $120 million.
- Perovskite-Info (October 30, 2026), “First Solar licenses CubicPV’s US perovskite patents” — independent confirmation of the license scope and the Oxford PV sequencing.
- Perovskite-Info company profile and Solar Power World (June 2021) — CubicPV’s formation from the Hunt Perovskite Technologies and 1366 Technologies merger, the $25 million investment including First Solar, and the Bedford, Massachusetts and Dallas offices.
- pv magazine USA (June 2023) and Perovskite-Info (February 2024) — the planned 10 GW wafer plant and its cancellation, citing wafer-price collapse and rising construction costs, and the restructuring around tandem development.
- Taiyang News (February 2026) and Solar Power World (February 2026) — the Oxford PV license terms and Oxford PV’s exclusive April 2025 licensing partnership with Trinasolar for China.
Background on perovskite patent crowding, freedom-to-operate practice, and large-area coating scale-up is drawn from the standard perovskite manufacturing literature and the companies’ own public descriptions; no royalty rate, patent count, efficiency figure, or deal term is stated in this article beyond what the companies disclosed, and undisclosed items are identified as undisclosed throughout.